At a Glance
| Methcathinone | 3-FEA | |
|---|---|---|
| Class | Entactogen, Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 100–200 mg | 35–70 mg |
| Total Duration | — | 2.3–4.5 hrs |
| Routes | oral | insufflatedoral |
Methcathinone, a Entactogen, Stimulants, and 3-FEA, a Entactogen, Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Entactogen, Stimulantss, meaning they share a common pharmacological foundation. They share 23 documented effects in common, with 9 effects unique to Methcathinone and 16 unique to 3-FEA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Methcathinone | 3-FEA | |
|---|---|---|
| Class | Entactogen, Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 100–200 mg | 35–70 mg |
| Total Duration | — | 2.3–4.5 hrs |
| Routes | oral | insufflatedoral |
| Effects | 32 documented | 39 documented |
| Interaction | Caution | |
| Level | Methcathinone | 3-FEA |
|---|---|---|
| Threshold | 25 mg | 15 mg |
| Light | 50–100 mg | 20–35 mg |
| Common | 100–200 mg | 35–70 mg |
| Strong | 200–300 mg | 70–90 mg |
| Heavy | 300 mg | 90 mg |
| Level | Dose |
|---|---|
| Threshold | 15 mg |
| Light | 20–35 mg |
| Common | 35–60 mg |
| Strong | 50–60 mg |
| Heavy | 60 mg |
Methcathinone
3-FEA
Increased cardiovascular strain and neurotoxicity risk